Post Type Archives: News

SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – has reported record revenues in the APAC region, with construction set to begin on a major new manufacturing facility in Thailand in Q4 2025. Growth has been driven by rising demand across Southeast Asia, with key markets including Singapore, Australia, and […]

CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC, a private commercial-stage company providing innovative therapies for acute and life-threatening illnesses, today announced a definitive agreement for CorMedix to acquire Melinta. The selling shareholders will receive $300 million in total consideration at closing, […]

Arcinova, a Quotient Sciences company, and UK-based Contract Research Development and Manufacturing Organisation (CRDMO), has announced the appointment of Dr. Christian Dowdeswell as new Managing Director. Taking the reins from co-founder and Managing Director, Paul Ryan, who recently announced his retirement, Christian joins the firm at a busy time for the business which has recently […]

Purilogics, a Donaldson Life Sciences business specializing in biopharmaceutical membrane chromatography development, today announced the availability of its first manufacturing-grade product within its Purexa™ portfolio—Purexa NAEX (Novel Anion Exchange) Prep membrane technology—to support customers’ GMP processes. The Purexa NAEX Prep is the first Purilogics product to become available in manufacturing grade. Specifically designed for the […]

Hongene, a global CDMO focused on nucleic acid raw materials and medicines, has appointed Dr. Pieter Cullis, a renowned innovator in lipid nanoparticle (LNP) drug delivery, to its scientific advisory board. This strategic addition reinforces Hongene’s commitment to advancing RNA therapeutics. Dr. Cullis is widely recognized for his foundational contributions to LNP technology, including its […]

Axplora, a global leader in API small molecule manufacturing, today announced a significant investment at its Vizag site in India to expand production capacity and reinforce supply chain resilience. This announcement follows the successful completion of routine USFDA inspections in 2025 at both of Axplora’s Indian manufacturing sites, Vizag and Chennai, which form part of […]

ESTEVE acquires Regis Technologies, a United States-based Contract Development and Manufacturing Organization (CDMO), headquartered in Chicago. This strategic move allows ESTEVE CDMO (actively operating under the Esteve Química brand) a physical presence in the United States, expanding its contract development and manufacturing solutions for innovative small-molecule active pharmaceutical ingredients (APIs) across the entire drug development […]

Bristol Myers Squibb and Bain Capital today announced the creation of a new independent biopharmaceutical company focused on developing new therapies for autoimmune diseases that address significant unmet needs of patients. The newly formed company launches with five immunology assets in-licensed from BMS and a $300 million financing commitment that was led by Bain Capital. […]

Novo Nordisk announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds Lars Fruergaard Jørgensen, who will step down as president and chief executive officer on the same date. The company also announced other executive-level changes, effective 7 August. Mike Doustdar, currently Novo Nordisk’s […]

Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for the first six months of 2025 and updated full-year sales and operating profit outlook at CER. In the first six months of 2025, Novo Nordisk’s sales increased by 18% and operating profit increased by 29%, both at CER. Sales growth […]